New: NCI-funded clinical trial search
Mednet Logo
SpecialtiesRheumatology
Rheumatology

Rheumatology

Clinical discussions on autoimmune diseases, biologic therapies, vasculitis, and musculoskeletal conditions.

Recent Discussions

Can anabolic agents be used in a patient with history of radioactive iodine treatment for hyperthyroidism?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · UC Davis

This is an interesting question. When PTH was approved it had a black box warning for patients who had a history of radiation to the skeleton due to risk of potential osteosarcomas. The black box has been removed for the duration of use. Since we have another anabolic agent without that black box, I...

What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?

2
1 Answers

Mednet Member
Mednet Member
Rheumatology · University of Washington

RA-ILD occurs in about 7-10% of patient with RA. It is more common in males and in those with a history of smoking. Most are seropositive. The typical pattern on HRCT in 50-60% of RA-ILD patients is a UIP pattern followed by NSIP, OP, and even LIP is some cases. An experienced clinician with the hel...

How will you counsel patients regarding adverse effects of nemolizumab?

2 Answers

Mednet Member
Mednet Member
Dermatology · UCONN

The adverse effect profile for this drug is minimal and the safety signals that were seen in higher amounts than placebo are what I would consider to be inconvenient and not worrisome issues.

At what point would you consider anticoagulation in a pregnant patient with lupus nephritis and non-nephrotic range proteinuria?

1
3 Answers

Mednet Member
Mednet Member
Rheumatology · UT Southwestern Medical Center

If the patient does not have APS and does not have nephrotic range proteinuria, then the indication for presumptive anti-coagulation is unclear.

How do you approach treatment of RA with methotrexate in a patient with treated Hepatitis C and normal liver function?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · UTMB Health

Active hepatitis C infection can be present in the setting of normal liver function tests. So, I always check for the viral load, especially if the hep C treatment was done more than a few years ago. Here, the old alpha interferon-based treatments achieved a cure rate no better than 30%. The newer a...

How do you approach DMARD therapy in patients with rheumatoid arthritis and chronic hepatitis B?

2
2 Answers

Mednet Member
Mednet Member
Rheumatology · Pacific Northwest University of Health Sciences

Patients with hepatitis B core positivity, surface antigen positivity, and positive PCR for viral DNA, should be treated with entecavir prior to starting any DMARD. Given the DNA PCR is positive too, that indicates active viral replication and they may need treatment for a while before starting anyt...

How do you counsel patients on the use of topical nitroglycerin for Raynaud's?

3
1 Answers

Mednet Member
Mednet Member
Rheumatology · Johns Hopkins University

I am actually not a big fan of topical NTG for Raynaud phenomenon. We know that there is some significant systemic absorption and patients may have high rates of side effects (such as headache). These rates were as high as 30% in some of the studies, which I think is higher than we see with use of o...

Is there any evidence regarding bone density gains/fracture reduction in the setting of treatment with romosozumab after a two year course of teriparatide?

2
1 Answers

Mednet Member
Mednet Member
Rheumatology · Case Western Reserve University School of Medicine

There was a study by Ebina et al., PMID 34020048 titled "To investigate the effects of prior treatment and determine the predictors of a 12-month treatment response of romosozumab (ROMO) in 148 patients with postmenopausal osteoporosis".This study was a prospective, observational, and multicenter st...

How do you approach ongoing screening for TB in patients with a history of treated latent TB, but who have ongoing use of DMARDs and/or biologics given Quantiferon testing and PPD can remain positive?

6
1 Answers

Mednet Member
Mednet Member
Infectious Disease · Cornell Medical School

Interferon-release assays (such as Quantiferon) and PPD testing do not discriminate between infection, reinfection, and prior infection with TB. However, in most developed countries, the likelihood that a patient who has once been treated for LTBI becomes reinfected and develops LTBI again is low, i...

How do you approach discussing the pill burden of voclosporin with patients who already have to take a regimen such as MMF+HCQ+ACEi and possibly more?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · NYU Langone Health

Medication adherence and a chronic disease such as lupus is an issue regardless of the number of medications. For example, hydroxychloroquine is very effective, but studies often show poor adherence as measured blood levels may be undetectable or below the intended therapeutic target.For patients wi...